Project Grant R41NS137832

Award Date 9/10/24
Completion Date 9/14/25
Dollars Obligated $499K
Federal Grant Program
93.853
Assistance Type
Project Grant
Place of Performance
New York, USA
Similar Awards
This federal Project Grant award of $580,654 was provided by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286). The grant supports research and development of a novel interferometric diffuse optics (IDO) system to quantitatively and specifically measure cerebral blood flow in patients with delayed cerebral ischemia after subarachnoid hemorrhage. The project...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program provides $299,982 to Unandup, LLC to evaluate the safety and efficacy of their novel magnetic infusion platform for accelerating alteplase delivery to acute ischemic stroke clots. The project aims to use an in vivo rat model to support an Investigational Device Exemption (IDE) application for...
This federal Project Grant award, totaling $124,485, was provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The funding will support the development and testing of a Fused Imaging and Large Language Foundational Model (FILLM) to predict 90-day outcomes for acute ischemic stroke patients treated with endovascular therapy. The project aims to integrate...
This federal Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), provides $449,122.00 to Trustees of Dartmouth College to develop a small, non-invasive device capable of mapping the intracranial space and differentiating ischemic from hemorrhagic stroke. The award aims to validate the feasibility of this novel approach to non-invasive...
This federal Project Grant award, ID R01NS134810, was provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The $492,749 award, effective December 15, 2024, supports the development of a non-invasive magnetic resonance imaging (MRI) technique to map tissue acidosis and predict tissue fate in acute ischemic stroke. The University of Pittsburgh will lead this...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $619,969 to The Methodist Hospital Research Institute (HMRI) to develop the DEEPSTROKE+ augmented-intelligence framework for improved stroke triage and diagnosis. The goal is to create a mobile AI-powered diagnostic tool that can rapidly and accurately detect acute strokes,...
This federal Project Grant award, provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, is focused on using artificial intelligence (AI) to predict post-stroke cognitive impairment (PSCI) based on routine clinical and imaging data. The $2,575,013 award to Emory University, with sub-awards to Georgia Tech Research Corp and the University of Kansas Medical...
This federal Project Grant award, titled "Noninvasive Optical Assessment of Neuroprotection in Deep Hypothermic Circulatory Arrest Procedures", is funded by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The $630,982 award, granted on May 6, 2025 and running through February 28, 2030, supports a comprehensive study led by The General Hospital Corporation...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $666,530 Project Grant under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) to Weill Medical College of Cornell University. The objective of this 5-year project is to develop an MRI-based cerebral metabolic rate of oxygen consumption (CMRO2) mapping technique to evaluate ischemic lesion viability in acute stroke patients. The project aims to validate the MRI-based CMRO2...
The National Science Foundation awarded a $266,000 Project Grant to Columbia University under the NSF Technology, Innovation, and Partnerships federal grant program (CFDA 47.084) to develop a wearable noninvasive brain imaging device using near-infrared light-based time-domain diffuse optical tomography. The device aims to improve clinical outcomes in neurology by enabling measurement of deep brain blood flow, which is difficult to measure with current technologies. The grant will support...

This $498,995 federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program supports the development of a highly parallelized interferometric near-infrared spectroscopy (INIRS) platform for the real-time, non-invasive measurement of cerebral blood flow. The research aims to address the limitations of current stroke diagnosis and monitoring techniques by creating a rapid, continuous, and quantitative method to assess critical factors like cerebral blood flow, volume, pressure, and closing pressure. The expected outcome is a validated minimum viable product capable of real-time cerebral blood flow measurement, which could have significant clinical impact on neurocritical care patient monitoring and point-of-care diagnosis and treatment of conditions like stroke and traumatic brain injury. The project will be conducted by the awardee, Neuralenz, Inc., over the period from September 2024 to September 2025.

Generated 7/1/25, 2:56 AM